Glenmark Pharmaceuticals to open US manufacturing facility

Mumbai, India-headquartered pharmaceutical company, Glenmark Pharmaceuticals, plans to open its first US manufacturing facility in Monroe, North Carolina this week (on 30th October 2018).

The  $100 million facility is Glenmark’s first manufacturing site in the US. It is designed to manufacture a variety of fixed-dose pharmaceutical formulations. At peak capacity, the site is anticipated to produce 300-400 million tablets and capsules, 20-25 million vials and prefilled syringes, and 25-30 million ampoules for inhaled formulations. The company has plans for further expansion in the coming years.

Globally, Glenmark now has 16 manufacturing facilities in Europe, India, and the US, which operate under GMP.